NEKTAR THERAPEUTICS
NKTR · NASDAQ
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.
ESG Scores
Overall ESG3.0
Environmental2.4
Social2.6
Governance4.6
Gender Diversity
Female Directors0.375%
Female Executives0.17094017094017094%
CEO GenderMale
Market Data
Price$84.86+0.87 (+1.04%)
Market Cap$2.43B
P/E Ratio—
EPS$—
52W High$86.95
52W Low$7.99
Beta1.22